XML 43 R32.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense is included in the consolidated results of operations as follows (in thousands):
 
Three months ended December 31,
 
2016
 
2015
Cost of sales
$
62

 
$
54

Sales and marketing
340

 
199

Research and development
182

 
148

General and administrative
589

 
410

Stock-based compensation before income taxes
1,173

 
811

Income tax benefit
(375
)
 
(257
)
Stock-based compensation after income taxes
$
798

 
$
554

Schedule of Stock Option Activity
The following table summarizes our stock option activity (in thousands, except per common share amounts):
 
 
Options Outstanding
 
Weighted Average Exercised Price
 
Weighted Average Contractual Term (in years)
 
Aggregate Intrinsic Value (1)
Balance at September 30, 2016
 
3,963

 
$10.36
 
 
 
 
Granted
 
598

 
12.87
 
 
 
 
Exercised
 
(263
)
 
10.60
 
 
 
 
Forfeited / Canceled
 
(204
)
 
13.43
 
 
 
 
Balance at December 31, 2016
 
4,094

 
$10.56
 
5.0
 
$
13,397

 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2016
 
2,625

 
$10.23
 
4.1
 
$
9,586

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $13.75 as of December 31, 2016, which would have been received by the option holders had all option holders exercised their options as of that date. The intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price.
Schedule of Valuation Assumptions
The table below shows the weighted average fair value, which was determined based upon the fair value of each option on the grant date utilizing the Black-Scholes option-pricing model and the related assumptions:
 
Three months ended December 31,
 
2016
 
2015
Weighted average per option grant date fair value
$4.64
 
$4.30
Assumptions used for option grants:
 
 
 
Risk free interest rate
1.46% - 1.96%
 
1.85%
Expected term
6.00 years
 
6.00 years
Expected volatility
33% - 34%
 
32%
Weighted average volatility
34%
 
32%
Expected dividend yield
0
 
0
Schedule of Nonvested Restricted Stock Units
A summary of our non-vested restricted stock units as of December 31, 2016 and changes during the three months then ended is presented below (in thousands, except per common share amounts):
 
Number of Awards
 
Weighted Average Grant Date Fair Value
Nonvested at September 30, 2016
505

 
$
9.67

Granted
248

 
$
12.74

Vested
(92
)
 
$
9.46

Nonvested at December 31, 2016
661

 
$
10.85